These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15848672)

  • 1. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
    Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First MR
    Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified release tacrolimus.
    First MR; Fitzsimmons WE
    Yonsei Med J; 2004 Dec; 45(6):1127-31. PubMed ID: 15627307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily tacrolimus in living donor liver transplant recipients.
    Sugawara Y; Miyata Y; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
    Biosci Trends; 2011 Aug; 5(4):156-8. PubMed ID: 21914950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
    Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
    Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.
    Heffron TG; Pescovitz MD; Florman S; Kalayoglu M; Emre S; Smallwood G; Wisemandle K; Anania C; Dhadda S; Sawamoto T; Keirns J; Fitzsimmons W; First MR
    Am J Transplant; 2007 Jun; 7(6):1609-15. PubMed ID: 17511684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
    Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients.
    Zhang YF; Chen XY; Dai XJ; Leng XS; Zhong DF
    Acta Pharmacol Sin; 2011 Nov; 32(11):1419-23. PubMed ID: 21963896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR
    Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once- versus twice-daily tacrolimus: are the formulations truly equivalent?
    Barraclough KA; Isbel NM; Johnson DW; Campbell SB; Staatz CE
    Drugs; 2011 Aug; 71(12):1561-77. PubMed ID: 21861541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients.
    Glowacki F; Lionet A; Hammelin JP; Labalette M; Provôt F; Hazzan M; Broly F; Noël C; Cauffiez C
    Clin Pharmacokinet; 2011 Jul; 50(7):451-9. PubMed ID: 21528942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study.
    Sukkha S; Chindavijak B; Montakantikul P; Ingsathit A; Nosoongnoen W; Sumethkul V
    Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation.
    Rubik J; Debray D; Iserin F; Vondrak K; Sellier-Leclerc AL; Kelly D; Czubkowski P; Webb NJA; Riva S; D'Antiga L; Marks SD; Rivet C; Tönshoff B; Kazeem G; Undre N
    Pediatr Transplant; 2019 Jun; 23(4):e13391. PubMed ID: 30932313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
    Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
    Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.